Cargando…
Tumor-suppressor role of miR-139-5p in endometrial cancer
BACKGROUND: Endometrial cancer (EC) is the fourth most common malignancy of the female genital tract worldwide. MicroRNAs are important gene regulators with critical roles in diverse biological processes, including tumorigenesis. Several study’s show that miR-139-5p is involved in the tumorigenesis...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879796/ https://www.ncbi.nlm.nih.gov/pubmed/29618950 http://dx.doi.org/10.1186/s12935-018-0545-8 |
_version_ | 1783311051865980928 |
---|---|
author | Liu, JinHui Li, ChunYu Jiang, Yi Wan, YiCong Zhou, ShuLin Cheng, WenJun |
author_facet | Liu, JinHui Li, ChunYu Jiang, Yi Wan, YiCong Zhou, ShuLin Cheng, WenJun |
author_sort | Liu, JinHui |
collection | PubMed |
description | BACKGROUND: Endometrial cancer (EC) is the fourth most common malignancy of the female genital tract worldwide. MicroRNAs are important gene regulators with critical roles in diverse biological processes, including tumorigenesis. Several study’s show that miR-139-5p is involved in the tumorigenesis and metastasis of various cancers. However, its expression and potential biologic role in endometrial cancer remain to be determined. This study aimed to investigate the miR-139-5p expression and to analyze its function and underlying molecular mechanism in endometrial cancer. METHODS: Expression of miR-139-5p was measured using qRT-PCR. The expression of HOXA10 was detected by Immunofluorescence staining in endometrial cancer tissues and adjacent normal tissues. CCK-8 and colony formation assays were used to assess the effect of miR-139-5p on ECC1 and Ishikawa cell line proliferation. Transwell migration assay was used to study the effect of miR-139-5p on EC cell migration. Luciferase reporter assay and western blot were used to confirm targeting of HOXA10 by miR-139-5p. RESULT: We demonstrated that miR-139-5p was down-regulated in human endometrial cancer compared to their matched adjacent non-tumor tissues. Overexpressed miR-139-5p significantly inhibited endometrial cancer cell viability and migration. Computational algorithm in combination with dual luciferase reporter assays identified HOXA10 as the target of miR-139-5p. HOXA10 expression was downregulated in endometrial cancer cells after miR-139-5p overexpression. The expression level of HOXA10 was significantly increased in endometrial cancer tissues, which was inversely correlated with miR-139-5p expression in clinical endometrial cancer tissues. CONCLUSION: These findings indicate that miR-139-5p targets the HOXA10 transcript and suppresses endometrial cancer cell growth and migration, suggesting that miR-139-5p acts as a tumor suppressive role in human endometrial cancer pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12935-018-0545-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5879796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58797962018-04-04 Tumor-suppressor role of miR-139-5p in endometrial cancer Liu, JinHui Li, ChunYu Jiang, Yi Wan, YiCong Zhou, ShuLin Cheng, WenJun Cancer Cell Int Primary Research BACKGROUND: Endometrial cancer (EC) is the fourth most common malignancy of the female genital tract worldwide. MicroRNAs are important gene regulators with critical roles in diverse biological processes, including tumorigenesis. Several study’s show that miR-139-5p is involved in the tumorigenesis and metastasis of various cancers. However, its expression and potential biologic role in endometrial cancer remain to be determined. This study aimed to investigate the miR-139-5p expression and to analyze its function and underlying molecular mechanism in endometrial cancer. METHODS: Expression of miR-139-5p was measured using qRT-PCR. The expression of HOXA10 was detected by Immunofluorescence staining in endometrial cancer tissues and adjacent normal tissues. CCK-8 and colony formation assays were used to assess the effect of miR-139-5p on ECC1 and Ishikawa cell line proliferation. Transwell migration assay was used to study the effect of miR-139-5p on EC cell migration. Luciferase reporter assay and western blot were used to confirm targeting of HOXA10 by miR-139-5p. RESULT: We demonstrated that miR-139-5p was down-regulated in human endometrial cancer compared to their matched adjacent non-tumor tissues. Overexpressed miR-139-5p significantly inhibited endometrial cancer cell viability and migration. Computational algorithm in combination with dual luciferase reporter assays identified HOXA10 as the target of miR-139-5p. HOXA10 expression was downregulated in endometrial cancer cells after miR-139-5p overexpression. The expression level of HOXA10 was significantly increased in endometrial cancer tissues, which was inversely correlated with miR-139-5p expression in clinical endometrial cancer tissues. CONCLUSION: These findings indicate that miR-139-5p targets the HOXA10 transcript and suppresses endometrial cancer cell growth and migration, suggesting that miR-139-5p acts as a tumor suppressive role in human endometrial cancer pathogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12935-018-0545-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-02 /pmc/articles/PMC5879796/ /pubmed/29618950 http://dx.doi.org/10.1186/s12935-018-0545-8 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Primary Research Liu, JinHui Li, ChunYu Jiang, Yi Wan, YiCong Zhou, ShuLin Cheng, WenJun Tumor-suppressor role of miR-139-5p in endometrial cancer |
title | Tumor-suppressor role of miR-139-5p in endometrial cancer |
title_full | Tumor-suppressor role of miR-139-5p in endometrial cancer |
title_fullStr | Tumor-suppressor role of miR-139-5p in endometrial cancer |
title_full_unstemmed | Tumor-suppressor role of miR-139-5p in endometrial cancer |
title_short | Tumor-suppressor role of miR-139-5p in endometrial cancer |
title_sort | tumor-suppressor role of mir-139-5p in endometrial cancer |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879796/ https://www.ncbi.nlm.nih.gov/pubmed/29618950 http://dx.doi.org/10.1186/s12935-018-0545-8 |
work_keys_str_mv | AT liujinhui tumorsuppressorroleofmir1395pinendometrialcancer AT lichunyu tumorsuppressorroleofmir1395pinendometrialcancer AT jiangyi tumorsuppressorroleofmir1395pinendometrialcancer AT wanyicong tumorsuppressorroleofmir1395pinendometrialcancer AT zhoushulin tumorsuppressorroleofmir1395pinendometrialcancer AT chengwenjun tumorsuppressorroleofmir1395pinendometrialcancer |